1. Home
  2. CRDO vs RGEN Comparison

CRDO vs RGEN Comparison

Compare CRDO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDO
  • RGEN
  • Stock Information
  • Founded
  • CRDO 2008
  • RGEN 1981
  • Country
  • CRDO Cayman Islands
  • RGEN United States
  • Employees
  • CRDO N/A
  • RGEN N/A
  • Industry
  • CRDO Semiconductors
  • RGEN Medical/Dental Instruments
  • Sector
  • CRDO Technology
  • RGEN Health Care
  • Exchange
  • CRDO Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CRDO 6.7B
  • RGEN 7.6B
  • IPO Year
  • CRDO 2022
  • RGEN N/A
  • Fundamental
  • Price
  • CRDO $68.51
  • RGEN $144.46
  • Analyst Decision
  • CRDO Strong Buy
  • RGEN Buy
  • Analyst Count
  • CRDO 10
  • RGEN 12
  • Target Price
  • CRDO $65.10
  • RGEN $187.44
  • AVG Volume (30 Days)
  • CRDO 5.1M
  • RGEN 531.4K
  • Earning Date
  • CRDO 12-02-2024
  • RGEN 11-12-2024
  • Dividend Yield
  • CRDO N/A
  • RGEN N/A
  • EPS Growth
  • CRDO N/A
  • RGEN N/A
  • EPS
  • CRDO N/A
  • RGEN N/A
  • Revenue
  • CRDO $245,588,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • CRDO $105.87
  • RGEN $2.23
  • Revenue Next Year
  • CRDO $55.64
  • RGEN $10.07
  • P/E Ratio
  • CRDO N/A
  • RGEN N/A
  • Revenue Growth
  • CRDO 48.40
  • RGEN N/A
  • 52 Week Low
  • CRDO $16.82
  • RGEN $113.50
  • 52 Week High
  • CRDO $78.97
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • CRDO 59.97
  • RGEN 45.89
  • Support Level
  • CRDO $64.87
  • RGEN $143.91
  • Resistance Level
  • CRDO $78.97
  • RGEN $161.24
  • Average True Range (ATR)
  • CRDO 5.81
  • RGEN 6.16
  • MACD
  • CRDO -0.59
  • RGEN -0.96
  • Stochastic Oscillator
  • CRDO 34.01
  • RGEN 12.10

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: